Net Spending On Retail Specialty Drugs Grew Rapidly, Especially For Private Insurance And Medicare Part D-Reference-Cited by-同舟云学术

Net Spending On Retail Specialty Drugs Grew Rapidly, Especially For Private Insurance And Medicare Part D

Published:2020-11-01 Issue:11 Volume:39 Page:1970-1976
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Hill Steven C.¹,Miller G. Edward²,Ding Yao³

Affiliation:

1. Steven C. Hill () is a senior economist in the Division of Research and Modeling, Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality (AHRQ), in Rockville, Maryland.

2. G. Edward Miller is deputy director of the Division of Research and Modeling, Center for Financing, Access, and Cost Trends, AHRQ.

3. Yao Ding is a senior economist in the Center for Financing, Access, and Cost Trends, AHRQ.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference8 articles.

1. Specialty Medications: Traditional And Novel Tools Can Address Rising Spending On These Costly Drugs

2. Specialty Drug Coupons Lower Out-Of-Pocket Costs And May Improve Adherence At The Risk Of Increasing Premiums

3. Share Of Specialty Drugs In Commercial Plans Nearly Quadrupled, 2003–14

4. Implications of the Accuracy of MEPS Prescription Drug Data for Health Services Research

5. Changes In Health Status And Care Use After ACA Expansions Among The Insured And Uninsured

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacy Benefit Managers;JAMA Health Forum;2023-11-03

2. Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs;JAMA Internal Medicine;2023-07-01

3. The Impact of Sharing Drug Rebates at the Point of Sale on Out-of-Pocket Payments for Enrollees in Employer-Sponsored Insurance;Value in Health;2023-02

4. Drug super spender tsunami: An integrated medical and pharmacy benefits assessment;Journal of Managed Care & Specialty Pharmacy;2022-11

5. Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study;Family Practice;2022-01-12